04 Dec, 2024 DLA Piper Genomics Series: Shaping the Future of Genomics - How Governments Worldwide Are Driving the Shift to Personalised Medicine By Kate Black As our Genomics mini-series has been exploring to date, genomic medicine is rapidly transforming healthcare across the globe, offering...
08 Oct, 2024 Introduction to the DLA Piper Genomics Series: An Insight into the ‘Genomics Revolution’ By Marion Abecassis Lyndsey Hudson Kate Black Ruth Faragher +1 more... Show less Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
19 Nov, 2024 DLA Piper Genomics Series: The UAE turns to genomics to provide world-class healthcare services By Adam Vause Celia Johnson-Morgan Katie Edwards Harnessing genomic technologies is revolutionising patient care by powering the evolution of personalised and precision medicine. The...
12 Nov, 2024 DLA Piper Genomics Series: CRISPR/Cas patent disputes – the position in Australia By Nicholas Tyacke Alex May The development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) systems for genome...
15 Oct, 2024 DLA Piper Genomics Series: From crisp packets to CRISPR, and beyond By Rebecca Lawrence Genome editing is an immensely powerful tool which has the potential to revolutionise the life sciences, including medicine and...
31 Oct, 2024 DLA Piper Genomics Series: From Gene-Edited Plants to Gene Drives: Unpacking Regulatory Debates By Mikael Kurki Pia Riemenschneider Lisa Weinekötter In this two-part article, we delve into the complexities of gene editing in plants and the ongoing EU legislative debates, followed by an...
19 Dec, 2024 Our Predictions for Life Sciences in 2025 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our Life Sciences team to share their predictions of what will be the key issues...
24 Oct, 2024 DLA Piper Genomics Series: Navigating Regulatory Challenges in the Era of Cell and Gene Therapies By Marion Abecassis Lyndsey Hudson Nicola Landolfi Ranulf Barman Marion de Galembert +2 more... Show less As healthcare moves towards personalised and precision medicine,[2] cell and gene therapies (CGTs) have emerged as cutting-edge and...
16 Dec, 2024 NIS2 Series, Part 3 - What happens if you don’t comply? An overview of enforcement, supervisory measures, and liability for management bodies By Andreas Rüdiger Philipp Adelberg Introduction The NIS2 Directive (NIS2 or the Directive) introduces extensive new cybersecurity requirements for a wide range of...
22 May, 2024 Inspirational Women in Life Sciences: Professor Dame Sue Hill By Kate Black Hannah Gardiner This week’s featured Inspirational Women in Life Sciences is Professor Dame Sue Hill, Chief Scientific Officer (CSO) for England. Dame...
28 Oct, 2024 NIS2 Series, Part 1 - Key features of the EU's new cybersecurity law and how it will apply to the life sciences sector By Nicholas de Lacy-Brown Abstract: The EU has expressly recognised the criticality of the life sciences sector by bringing pharmaceutical manufacturers, clinical...
28 Jun, 2024 Pride in Life Sciences Series 2024 By Alexandra de Zwart Ruth Faragher To mark Pride Month 2024, we have launched a new series to celebrate the LGBTQ+ community working in the life sciences sector. Visibility...
08 Mar, 2024 IWD: Inspirational Women in Life Sciences Series 2024 By Hannah Gardiner Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature inspirational women working in the Life Sciences sector....
07 Mar, 2022 HealthTech - Shifting Landscapes Series (Part 1): Overview By Hannah Gardiner HealthTech: Trends and Challenges In a recent internal webinar, DLA Piper and Global Data looked into the shifting landscape of...
31 Mar, 2022 HealthTech - Shifting Landscapes Series (Part 2): Software as a Medical Device By Hannah Gardiner Please note: This article is the second in our HealthTech - Shifting Landscapes Series. For an introduction to this series, overview of...
22 Jul, 2024 Pride in Life Sciences Series 2024: Alexander Toro Alvarez By Ruth Faragher Mathias Schulze Steinen Our series started in June to celebrate the LGBTQ+ community working in the life sciences sector. Visibility plays an important role in...